(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

TOXNET

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

TOXNET

ST13

US500000079292872

Classe

16, 35, 41, 42

Pedido

79292872

Registro

6726684

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

47

Atualização mais recente

06/12/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

16, 35, 41, 42

Data de depósito

03/03/2020

Data de registro

24/05/2022

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

24/05/2022

Última transação

06/12/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

DE

Examinador

STURMAN,MELISSA M

Unidade examinadora

N70

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Merz Pharma GmbH & Co. KGaA

Representantes

Salima Merani Ph.D. Knobbe, Martens, Olson & Bear, LLP

Classificação técnica

Classes Nice

Classe 16Classe 35Classe 41Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 16

Books in the field of medicine and aesthetic dermatology; printed matternewslettersmagazinespamphletswritten articles in the field of medicine and aesthetics dermatology; printed instructional and teaching material in the field of medicine and aesthetic dermatology; copy paper and stationery; printed periodicals in the field of medicine and aesthetic dermatology; magazines featuring medicine and aesthetic dermatology; newspapers; all the foregoing excluding the fields of toxicologytoxic substances and hazardous waste

Classe 35

Online advertising services for others; advertising services in the field of medicinecosmetic surgerybeautyaesthetic dermatology; advertising services for goods and services via websites; advertisingonline-advertisements via a global computer network; all the foregoing excluding the fields of toxicologytoxic substances and hazardous waste

Classe 41

Training seminars in the field of pharmaceuticals; medical training and teaching; vocational education services in the field of medicine and aesthetic dermatology; vocational education in the field of medicine for medical personnel; vocational education services in the field of cosmetics; providing onlinenon-downloadable publications in the nature of newslettersmagazinespamphletsspecialized journalsarticles in the field of medicine and aesthetic dermatology; providing non-downloadable electronic publications in the nature of blogs and articles in the field of medicine and aesthetic dermatology; arrangingconductingorganization of educational seminarsclassesworkshopscolloquiums in the field of aesthetic dermatology; organization of educational seminars and classes in the field of medicine; publishing and issuing of scientific papers in the field of medicine; publication of printed matterbooksmagazines; providing online non-downloadable electronic publications in the nature of newslettersmagazinespamphletsarticles in the field of medicinecosmetic surgerybeautyaesthetic dermatology; all the foregoing excluding the fields of toxicologytoxic substances and hazardous waste

Classe 42

Scientific research in the medical field; medical research and development of pharmaceuticals and cosmetics; medical research; medical and pharmaceutical research services; pharmaceutical research and development; scientific research and development; computer technological servicesproviding a website featuring an on-linenon-downloadablesoftware application for connecting users to databases which provide scientific and technical information on aesthetic dermatology and medicineexcluding databases in the fields of toxicologytoxic substances and hazardous waste; all the foregoing excluding the fields of toxicologytoxic substances and hazardous waste

Publicações

Histórico de despachos e eventos da marca no USPTO.

47 publicações encontradas

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/12/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/10/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

07/09/2022

FIMP

FINAL DISPOSITION PROCESSED

07/09/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

24/08/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

24/05/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

24/05/2022

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

07/03/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/03/2022

PUBO

PUBLISHED FOR OPPOSITION

01/03/2022

GPNX

NOTIFICATION PROCESSED BY IB

27/02/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

16/02/2022

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

16/02/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

09/02/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

09/02/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/02/2022

EXPT

EXPARTE APPEAL TERMINATED

25/01/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

25/01/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

25/01/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

25/01/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

25/01/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

25/01/2022

DOCK

ASSIGNED TO EXAMINER

03/12/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/11/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/11/2021

ALIE

ASSIGNED TO LIE

10/11/2021

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

08/11/2021

EXPI

EX PARTE APPEAL-INSTITUTED

08/11/2021

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

08/11/2021

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

08/11/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

13/05/2021

GNFR

FINAL REFUSAL E-MAILED

13/05/2021

CNFR

FINAL REFUSAL WRITTEN

13/05/2021

DOCK

ASSIGNED TO EXAMINER

02/04/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

31/03/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

31/03/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

31/03/2021

RFNT

REFUSAL PROCESSED BY IB

25/10/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/10/2020

RFRR

REFUSAL PROCESSED BY MPU

03/10/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

15/09/2020

MAFR

APPLICATION FILING RECEIPT MAILED

15/09/2020

CNRT

NON-FINAL ACTION WRITTEN

14/09/2020

DOCK

ASSIGNED TO EXAMINER

11/09/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/09/2020

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

09/09/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/09/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace TOXNET ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.